Verdict85/ 100
Grade B · #17Hims & Hers
Editorial reviewMass-market, app-first weight program with nationwide reach and consumer-grade polish.
Visit Hims & HersHead-to-head verdict
Hims & Hers vs Vaylen
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.
vs
Verdict88/ 100
Grade B+ · #5Vaylen
Editorial reviewThe widest formulary on the board — both molecules, brand-name and oral routes — nationwide and LegitScript-verified.
Visit VaylenThe verdict
Winner: Vaylen
Vaylen takes it with a higher Verdict Score — 88/100 to 85/100 (grade B+ vs B). Anyone who wants every option on one account: compounded, brand-name or oral, without leaving to shop around. Hims & Hers still earns its place — people who want a familiar, app-driven consumer brand.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
86Real-world results86
86
Real-world results86
83Price honesty87
83
Price honesty87
90Prescriber access90
90
Prescriber access90
80Formulary choice91
80
Formulary choice91
84Cancellation fairness86
84
Cancellation fairness86
86Member support86
86
Member support86
Price, coverage & features
| Metric | Hims & Hers | Vaylen |
|---|---|---|
| Verdict Score | 85/100 | 88/100 |
| Grade | B | B+ |
| Semaglutide | $199/mo | $179/mo |
| Tirzepatide | Not disclosed | $239/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
| Relationship | Editorial | Editorial |
Hims & Hers
What we like
- Nationwide
- Slick app experience
- Strong brand trust
The caveats
- Tirzepatide pricing not consistently disclosed
- Compounded supply has drawn regulatory scrutiny industry-wide
Vaylen
What we like
- Full formulary: both molecules plus brand-name and oral routes
- LegitScript-certified and available in all 50 states
- Fair mid-market pricing for the breadth on offer
The caveats
- Not the cheapest per molecule
- Younger brand without a long outcomes record
Also worth a look
People who want a familiar, app-driven consumer brand.
Visit Hims & Hers Read the full Hims & Hers review →Our pick — visit
Anyone who wants every option on one account: compounded, brand-name or oral, without leaving to shop around.
Visit Vaylen Read the full Vaylen review →Keep comparing
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.